DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...

Confused by a contract? Docusign's AI will explain it now - but don't skip the fact-check ...

Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...

Docusign's growth has slowed post-pandemic, with revenue growth at 7.78% YoY in FY2025 and a slight dip in client count, raising concerns about future prospects. Despite operational strengths like a ...